389 related articles for article (PubMed ID: 1692629)
21. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H.
Haque A; Cortes C; Alam MN; Sreedhar M; Ferreira VP; Pangburn MK
Front Immunol; 2020; 11():1728. PubMed ID: 32849614
[TBL] [Abstract][Full Text] [Related]
23. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.
Sharma AK; Pangburn MK
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10996-1001. PubMed ID: 8855297
[TBL] [Abstract][Full Text] [Related]
24. Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.
Fries LF; Prince GM; Gaither TA; Frank MM
J Immunol; 1985 Oct; 135(4):2673-9. PubMed ID: 3161945
[TBL] [Abstract][Full Text] [Related]
25. Self-nonself discrimination by the complement system.
Meri S
FEBS Lett; 2016 Aug; 590(15):2418-34. PubMed ID: 27393384
[TBL] [Abstract][Full Text] [Related]
26. A new map of glycosaminoglycan and C3b binding sites on factor H.
Schmidt CQ; Herbert AP; Kavanagh D; Gandy C; Fenton CJ; Blaum BS; Lyon M; Uhrín D; Barlow PN
J Immunol; 2008 Aug; 181(4):2610-9. PubMed ID: 18684951
[TBL] [Abstract][Full Text] [Related]
27. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.
Pangburn MK; Morrison DC; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1980 Feb; 124(2):977-82. PubMed ID: 7356723
[No Abstract] [Full Text] [Related]
28. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
Schenkman S; Güther ML; Yoshida N
J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
[TBL] [Abstract][Full Text] [Related]
29. Activation of complement via the alternative pathway.
Pangburn MK
Fed Proc; 1983 Jan; 42(1):139-43. PubMed ID: 6217084
[TBL] [Abstract][Full Text] [Related]
30. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
Medicus RG; Melamed J; Arnaout MA
Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
[TBL] [Abstract][Full Text] [Related]
31. Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.
Nydegger UE; Fearon DT; Austen KF
Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6078-82. PubMed ID: 282625
[TBL] [Abstract][Full Text] [Related]
32. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
33. Activation of the alternative complement pathway.
Fearon DT
CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
[No Abstract] [Full Text] [Related]
34. Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b.
Koistinen V
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):255-9. PubMed ID: 1835839
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway.
Boackle RJ; Caughman GB; Vesely J; Medgyesi G; Fudenberg HH
Mol Immunol; 1983 Nov; 20(11):1157-64. PubMed ID: 6228720
[TBL] [Abstract][Full Text] [Related]
36. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
Ezzell JL; Parker CJ
Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
[TBL] [Abstract][Full Text] [Related]
37. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
Koistinen V; Wessberg S; Leikola J
Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
[TBL] [Abstract][Full Text] [Related]
38. Control of the immune complex-complement interaction by protein H of the alternative complement pathway and the natural inhibitor heparin.
Spycher MO; Nydegger UE
Eur J Immunol; 1984 Mar; 14(3):276-9. PubMed ID: 6231187
[TBL] [Abstract][Full Text] [Related]
39. Activation of the alternative pathway of complement: efficient fluid-phase amplification by blockade of the regulatory complement protein beta1H through sulfated polyanions.
Bitter-Suermann D; Burger R; Hadding U
Eur J Immunol; 1981 Apr; 11(4):291-5. PubMed ID: 6454580
[TBL] [Abstract][Full Text] [Related]
40. Lysine residues, but not carbohydrates, are required for the regulatory function of H on the amplification C3 convertase of complement.
Jouvin MH; Kazatchkine MD; Cahour A; Bernard N
J Immunol; 1984 Dec; 133(6):3250-4. PubMed ID: 6238095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]